<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02117557</url>
  </required_header>
  <id_info>
    <org_study_id>NFGS-SILS-01</org_study_id>
    <nct_id>NCT02117557</nct_id>
  </id_info>
  <brief_title>Safety Study of Transumbilical Single Incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer</brief_title>
  <official_title>A Prospective Randomized Controlled Trial Comparing Transumbilical Single Incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guoxin Li</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nanfang Hospital of Southern Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  Compared with traditional open colectomy, laparoscopic surgery is associated with less
           pain, earlier recovery, and better cosmetic outcome, and its short- and long-term
           oncologic outcomes have been demonstrated.

        -  In experienced surgeons' hands, single incision laparoscopic surgery is increasingly
           performed for colorectal disease, and even for malignant lesion because of its reduced
           incision-associated morbidity and scarring.

        -  However, the safety and efficacy of single incision laparoscopic surgery for colorectal
           cancer has not yet been evaluated. Thus, the prospective randomized trial comparing
           single incision versus conventional laparoscopic surgery for colorectal cancer is
           needed.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2017</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Early morbidity rate</measure>
    <time_frame>30 days</time_frame>
    <description>The early morbidity rate is defined as the event observed during operation and within 30 days after surgery,</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Operative outcomes</measure>
    <time_frame>intraoperative</time_frame>
    <description>Operative time, estimated blood loss and incision length are recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pathological outecomes</measure>
    <time_frame>5 days</time_frame>
    <description>Tumor size, length of proximal and distal margin and lymph nodes harvested are used to assess oncological resection.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative recovery course</measure>
    <time_frame>14 days</time_frame>
    <description>Time to first ambulation, flatus, liquid diet, soft diet, and duration of hospital stay are used to assess the postoperative recoverty course.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain score</measure>
    <time_frame>14 days</time_frame>
    <description>Postoperative pain is recorded using the visual analog scale (VAS) pain score tool on postoperative day 1, 2, 3 and the day of discharge.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cosmetic assessment</measure>
    <time_frame>14 days</time_frame>
    <description>Cosmetic assessment is perform using body image scale and cosmetic scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>3-year disease free survival rate</measure>
    <time_frame>36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>5-year overall survival rate</measure>
    <time_frame>60 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory and immune response</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">198</enrollment>
  <condition>Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>Single incision laparoscopic surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transumbilical single incision laparoscopic surgery will be performed for patients in this group.And addition of only one trocar through the stoma for drainage tube is allowed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional laparoscopic surgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional laparoscopic surgery for colorectal cancer will be performed for patients in this group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Single incision laparoscopic surgery</intervention_name>
    <arm_group_label>Single incision laparoscopic surgery</arm_group_label>
    <other_name>SILS</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conventional laparoscopic surgery</intervention_name>
    <arm_group_label>Conventional laparoscopic surgery</arm_group_label>
    <other_name>CLS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years &lt; age &lt; 80 years

          -  Tumor located in rectosigmoid (defined as 10- to 30-cm from the anal verge)

          -  Pathological rectosigmoid carcinoma

          -  Preoperative T stage ranging from T1 to T4a according to the 7th Edition of AJCC
             Cancer Staging Manual

          -  Tumor size of 5 cm or less; 6) ECOG score is 0-1

          -  ASA socre is Ⅰ-Ⅲ

          -  Informed consent

        Exclusion Criteria:

          -  Body mass index (BMI) &gt;30 kg/m2

          -  Pregnant woman or lactating woman

          -  Severe mental disease

          -  Previous abdominal surgery

          -  Emergency operation due to complication (bleeding, perforation or obstruction) caused
             by colorectal cancer

          -  Requirement of simultaneous surgery for other disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guoxin Li, M.D., PH.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nanfang Hospital, Southern Medical University, China</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Guoxin Li, M.D., PH.D.</last_name>
    <phone>+86-138-0277-1450</phone>
    <email>gzliguoxin@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yanan Wang, M.D.</last_name>
    <phone>+86-150-1875-3181</phone>
    <email>wyn8116@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Nanfang Hospital, Southern Medical University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510-515</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guoxin Li, M.D.,PH.D.</last_name>
      <phone>+86-138-0277-1450</phone>
      <email>gzliguoxin@163.com</email>
    </contact>
    <investigator>
      <last_name>Guoxin Li, M.D.,PH.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yanan Wang, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Haijun Deng, M.D.,PH.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Qi Xue, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Bucher P, Pugin F, Morel P. Single-port access laparoscopic radical left colectomy in humans. Dis Colon Rectum. 2009 Oct;52(10):1797-801. doi: 10.1007/DCR.0b013e3181b551ce.</citation>
    <PMID>19966617</PMID>
  </reference>
  <reference>
    <citation>Gash KJ, Goede AC, Chambers W, Greenslade GL, Dixon AR. Laparoendoscopic single-site surgery is feasible in complex colorectal resections and could enable day case colectomy. Surg Endosc. 2011 Mar;25(3):835-40. doi: 10.1007/s00464-010-1275-8. Epub 2010 Aug 24.</citation>
    <PMID>20734083</PMID>
  </reference>
  <reference>
    <citation>Lim SW, Kim HJ, Kim CH, Huh JW, Kim YJ, Kim HR. Umbilical incision laparoscopic colectomy with one additional port for colorectal cancer. Tech Coloproctol. 2013 Apr;17(2):193-9. doi: 10.1007/s10151-012-0900-z. Epub 2012 Sep 19.</citation>
    <PMID>22991135</PMID>
  </reference>
  <reference>
    <citation>Hirano Y, Hattori M, Douden K, Shimizu S, Sato Y, Maeda K, Hashizume Y. Single-incision plus one port laparoscopic anterior resection for rectal cancer as a reduced port surgery. Scand J Surg. 2012;101(4):283-6.</citation>
    <PMID>23238505</PMID>
  </reference>
  <verification_date>April 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 16, 2014</study_first_submitted>
  <study_first_submitted_qc>April 17, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 21, 2014</study_first_posted>
  <last_update_submitted>April 17, 2014</last_update_submitted>
  <last_update_submitted_qc>April 17, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 21, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Nanfang Hospital of Southern Medical University</investigator_affiliation>
    <investigator_full_name>Guoxin Li</investigator_full_name>
    <investigator_title>M.D., Ph.D.</investigator_title>
  </responsible_party>
  <keyword>Single-incision</keyword>
  <keyword>Laparoscopy</keyword>
  <keyword>Colorectal Cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Surgical Wound</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

